Clinicopathological characteristics of patients with HER2-positive breast cancer and the efficacy of trastuzumab in the People’s Republic of China

OBJECTIVE: The aim of this study was to describe the clinical features and outcomes of Chinese patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer. METHOD: The clinical data and survival statuses of 732 patients with operable HER2-positive breast cancer who were trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ping, Jiang, Yi-Zhou, Hu, Xin, Sun, Wei, Liu, Yi-Rong, Liu, Fang, Luo, Rong-Cheng, Shao, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846044/
https://www.ncbi.nlm.nih.gov/pubmed/27143924
http://dx.doi.org/10.2147/OTT.S97583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846044/
https://www.ncbi.nlm.nih.gov/pubmed/27143924
http://dx.doi.org/10.2147/OTT.S97583

Ejemplares similares